SCHEMBL627385

SCHEMBL627385

CC(=O)OC1CCC(Nc2nn3cc(I)nc3s2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.39
FYN P06241 9/20 0.35
PDE10A Q9Y233 1/20 0.35
CCNA2 P20248 2/20 0.34
CDK2 P24941 2/20 0.34
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
HASPIN Q8TF76 1/20 0.32
PI4KB Q9UBF8 2/20 0.32
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 1/20 0.31
NR2F2 P24468 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPK1 P28482 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
S1PR2 O95136 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628244 0.78 MAPK1 (0.36) FYNPDE10ACDK2MAPK1
SCHEMBL627384 0.77 FYN (0.48) NPY5RFYNPDE10AHASPIN
SCHEMBL627537 0.76 FYN (0.37) NPY5RFYNPDE10AHASPIN
SCHEMBL627536 0.76 FYN (0.37) NPY5RFYNPDE10AHASPIN
SCHEMBL625118 0.75 POLB (0.31) MAPTMAPK1
SCHEMBL2255671 0.64 ALDH1A1 (0.41) FYNADORA2AADORA1MAPTALDH1A1
SCHEMBL1946929 0.64 TP53 (0.51) FYNMAPTKDM4EMEN1NPC1
SCHEMBL1944906 0.64 FYN (0.47) FYNMAPTKDM4EMEN1NPC1
SCHEMBL627055 0.64 MAPT (0.48) MAPTKDM4EMEN1LMNAKMT2A
SCHEMBL1944534 0.63 FYN (0.44) FYNMAPTKDM4EMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed